A PHASE 2 STUDY OF LONAFARNIB, RITONAVIR AND PEGINTERFERON LAMBDA FOR 24 WEEKS: INTERIM END-OF-TREATMENT RESULTS FROM THE LIFT HDV STUDY.Christopher Koh,Ben L. Da,Pallavi Surana,Amy Huang,Devika Kapuria,Yaron Rotman,Anusha Vittal,Christy Gilman,Gil Ben-Yakov, Chunwei Lai,David Kleiner,Farial Rahman,Julian Hercun,Harel Dahari,Jeffrey Glenn,Theo HellerHEPATOLOGY（2019）引用 13|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
